CN104041900A - 一种解酒养生植物饮品及其制备方法 - Google Patents
一种解酒养生植物饮品及其制备方法 Download PDFInfo
- Publication number
- CN104041900A CN104041900A CN201410292530.8A CN201410292530A CN104041900A CN 104041900 A CN104041900 A CN 104041900A CN 201410292530 A CN201410292530 A CN 201410292530A CN 104041900 A CN104041900 A CN 104041900A
- Authority
- CN
- China
- Prior art keywords
- effect
- parts
- alcohol
- health
- plant beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- 241000196324 Embryophyta Species 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- 239000000796 flavoring agent Substances 0.000 claims abstract description 13
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 12
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 10
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 10
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 10
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 10
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 235000015165 citric acid Nutrition 0.000 claims abstract description 3
- 238000001914 filtration Methods 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 12
- 239000012452 mother liquor Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241001092040 Crataegus Species 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 235000020717 hawthorn extract Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 241001065361 Gynostemma Species 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 11
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000002207 metabolite Substances 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 230000008030 elimination Effects 0.000 abstract description 3
- 238000003379 elimination reaction Methods 0.000 abstract description 3
- 238000010579 first pass effect Methods 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000035900 sweating Effects 0.000 abstract description 2
- 235000017159 Crataegus pinnatifida Nutrition 0.000 abstract 1
- 241000657480 Crataegus pinnatifida Species 0.000 abstract 1
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 1
- 244000010000 Hovenia dulcis Species 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000036578 sleeping time Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000003813 thumb Anatomy 0.000 abstract 1
- 239000000047 product Substances 0.000 description 8
- -1 flavone compound Chemical class 0.000 description 5
- 238000003304 gavage Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 2
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- OQAGVSWESNCJJT-UHFFFAOYSA-N Methyl 3-methylbutanoate Chemical compound COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002075 anti-alcohol Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 230000010224 hepatic metabolism Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- RUDVAOJNIYYYCQ-HUIKYQPJSA-N (1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosane-7,16-diol Chemical group CC(C)=C[C@H]1C[C@](C)(O)[C@@H]2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@@]33CO[C@@]2(C3)O1 RUDVAOJNIYYYCQ-HUIKYQPJSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- VSMOENVRRABVKN-MRVPVSSYSA-N 1-Octen-3-ol Natural products CCCCC[C@H](O)C=C VSMOENVRRABVKN-MRVPVSSYSA-N 0.000 description 1
- YDXQPTHHAPCTPP-UHFFFAOYSA-N 3-Octen-1-ol Natural products CCCCC=CCCO YDXQPTHHAPCTPP-UHFFFAOYSA-N 0.000 description 1
- QTVAYNGFFDZGDR-CIJVEFAYSA-N 5-hydroxy-6-methoxy-3-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)O3)O)=C(OC)C(O)=C2C1=O QTVAYNGFFDZGDR-CIJVEFAYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 229930191576 Biochanin Natural products 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- QZYVSOVGZWRNEK-UHFFFAOYSA-N Hovenoside D Natural products CC(=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(COC8OC(CO)C(O)C(O)C8OC9OCC(O)C(O)C9O)C(O)C(O)C7O)C6OC%10OCC(O)C(O)C%10O)C(C)(C)C5CCC4(C)C3%11COC2(C%11)O1)C QZYVSOVGZWRNEK-UHFFFAOYSA-N 0.000 description 1
- QVKNFOCNXKZPMO-UHFFFAOYSA-N Hovenoside G Natural products CC1(C)C2CCC3(C)C4(C5)COC65OC(C=C(C)C)CC(C)(O)C6C4CCC3C2(C)CCC1OC(C1OC2C(C(O)C(O)CO2)O)OCC(O)C1OC1OC(CO)C(O)C(O)C1OC1OCC(O)C(O)C1O QVKNFOCNXKZPMO-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- MGJLSBDCWOSMHL-WFMNFSIZSA-N Ononin Natural products O(C)c1ccc(C=2C(=O)c3c(OC=2)cc(O[C@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc3)cc1 MGJLSBDCWOSMHL-WFMNFSIZSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WUADCCWRTIWANL-UHFFFAOYSA-N biochanin A Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O WUADCCWRTIWANL-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229930186938 hovenoside Natural products 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- RUDVAOJNIYYYCQ-UHFFFAOYSA-N jujubogenin Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)(O)CC(C=C(C)C)OC33OCC21C3 RUDVAOJNIYYYCQ-UHFFFAOYSA-N 0.000 description 1
- MYJXWCIZOOKQLK-UHFFFAOYSA-N kakkalide Natural products COc1cc2C(=O)C(=COc2cc1OC3OC(COC4OCC(O)C(O)C4O)C(O)C(O)C3O)c5ccc(O)cc5 MYJXWCIZOOKQLK-UHFFFAOYSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- MGJLSBDCWOSMHL-MIUGBVLSSA-N ononin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=C2C1=O MGJLSBDCWOSMHL-MIUGBVLSSA-N 0.000 description 1
- MGJLSBDCWOSMHL-UHFFFAOYSA-N ononoside Natural products C1=CC(OC)=CC=C1C1=COC2=CC(OC3C(C(O)C(O)C(CO)O3)O)=CC=C2C1=O MGJLSBDCWOSMHL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- SVICABYXKQIXBM-UHFFFAOYSA-L potassium malate Chemical compound [K+].[K+].[O-]C(=O)C(O)CC([O-])=O SVICABYXKQIXBM-UHFFFAOYSA-L 0.000 description 1
- 239000001415 potassium malate Substances 0.000 description 1
- 235000011033 potassium malate Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种解酒养生植物饮品及其制备方法，而提供一种既具有解酒醒酒效果，同时，具有养生保健功能的植物饮品及其制备方法。该饮品按照重量份数的原料组成为：绞股蓝1-10，甘草1-7，枳椇子10-25，葛根15-45，葛花10-35，山楂1-10。还包括由白砂糖、柠檬酸、山梨酸钾和果味香精组成的矫味剂。各个原料之间通过合理配比及协同作用，通过发汗、利尿、通便等功效抑制酒精的肠胃吸收，加强乙醇在胃肠道的首过效应，降低血中乙醇的浓度，同时，药物直接作用于肝代谢酶系统，增强乙醇脱氢酶活性，加速乙醇及其代谢产物的消除速率，减轻其对组织和细胞的损害,解酒功效十分明显，睡眠时间缩短，醒酒恢复时间为62.3分钟。
Description
技术领域
本发明涉及一种以中药为原料配制而成的解酒养生植物饮品及其制备方法。
背景技术
近年来我国酗酒和酒精中毒者日益增多，严重影响人们身体健康和家庭、社会的稳定。酒对人体有广泛的药理作用，急性大量饮酒可以引起恶心、呕吐、记忆力减退，注意力不集中、精细运动能力受损和情绪不稳定，严重时甚至可因呼吸和肌肉麻痹而导致死亡。长期饮酒可以引起精神障碍，胃溃疡以及脂肪肝、酒精性肝炎、肝硬化等疾病。有资料表明食道癌、肝癌发病率的升高似乎也与饮酒有关。因此，开发有效的解酒养生食品受到人们的普遍重视。目前西方开发的解酒产品以合成药物为主，而亚洲国家则侧重天然药物的研究开发。
天然解酒药物的作用核心就是降低患者血中乙醇及其代谢产物的浓度，减轻其对各个器官的损伤。当前的药物主要从两个方面发挥解酒作用：其一是肠胃吸收抑制剂，主要作用是抑制酒精的肠胃吸收，加强乙醇在胃肠道的首过效应，降低血中乙醇的浓度；其二是代谢增强剂，药物直接作用于肝代谢酶系统，加速乙醇及其代谢产物的消除速率，减轻其对组织和细胞的损害。
目前市场上出现的解酒产品，并未被广大消费者认同。其原因是一些产品并没有所描述的醒酒效果，醒酒需要的时间长，醒酒作用不显著，而且，很大一部分产品风味不好，多含有较浓的中草药味，让人难以接受。
发明内容
本发明的目的是针对现有技术中存在的技术缺陷，而提供一种既具有解酒醒酒效果，同时，具有养生保健功能的植物饮品。
本发明的另一个目的是提供一种具有良好口感的植物饮品。
本发明的再一个目的是提供一种解酒养生植物饮品的制备方法。
为实现本发明的目的所采用的技术方案是：
一种解酒养生植物饮品，按照重量份数的原料组成为：绞股蓝1-10，甘草1-7，枳椇子10-25，葛根15-45，葛花10-35，山楂1-10。
还包括辅料，所述辅料为矫味剂，所述矫味剂由白砂糖、柠檬酸、山梨酸钾和果味香精组成，按照重量份数白砂糖为6-15，柠檬酸为0.1-0.5，山梨酸钾为0.04，果味香精为0.05-0.2。
一种所述的解酒养生植物饮品的制备方法，包括下述步骤：
(1)制取含有绞股蓝、甘草、枳椇子、葛根、葛花和山楂提取液的混合液，之后，70℃以下浓缩使得可溶性固形物含量在20％-99.9％作为母液；制取所述母液的原料按照重量份数绞股蓝1-10，甘草1-7，枳椇子10-25，葛根15-45，葛花10-35，山楂1-10；
(2)取所述母液与白砂糖柠檬酸、山梨酸钾和果味香精混合溶解后定容，经过滤、均质、灭菌、灌浆、包装得到解酒养生植物饮品；按照重量份数比母液为0.5-30，白砂糖为6-15，柠檬酸0.1-0.5，山梨酸钾为0.04，果味香精为0.05-0.2。
所述母液的制备方法如下：
(1)按照重量份数为1-10：1-7：10-25：15-45：10-35：1-10的比例称量含水量在13％以下的绞股蓝、甘草、枳椇子、葛根、葛花、山楂混合，放入提取釜中；
(2)向提取釜中注入10倍的纯净水，在70℃条件下浸提2小时，滤渣中再加入8倍量的纯净水，70℃下浸提1.5小时，过滤后合并得到粗滤液；
(3)粗滤液先用纱布过滤，然后用抽滤装置进行硅藻土上过滤，得红褐色滤液；
(4)红褐色滤液用旋转浓缩仪于70℃抽真空浓缩至相当于含可溶性固形物0.20g-0.99g/g。
与现有技术相比，本发明的有益效果是：
1、本发明的植物饮品采用中药配方，绞股蓝有降血脂、降血压、降血糖、镇静、催眠、抗紧张以及增进食欲，增强抵抗力，通畅大便，平喘止咳，消痔、减肥等多种功效；甘草有治五脏六腑寒热邪气，坚筋骨，长肌肉，倍气力，解毒，散表寒，去咽痛，除邪热，缓正气，养阴血，补脾胃，润肺等多种功效；枳椇子味甘、性平、无毒，有止渴除烦，去膈上热，润五脏，利大小便，解酒毒等功效；葛根能够提高肝细胞的再生能力，恢复正常肝脏机能，促进胆汁分泌，防止脂肪在肝脏堆积，并能促进新陈代谢，加强肝脏解毒功能，防止酒精对肝脏的损伤，葛根素有明显的降低血糖的作用，所含的黄酮类化合物有降血脂等疗效；葛花有治饮酒积热，毒伤脾胃，呕血吐血，发热烦渴，小便赤少等功效；山楂有消积，行瘀，化滞等作用。各个原料之间通过合理配比及协同作用，通过发汗、利尿、通便等功效抑制酒精的肠胃吸收，加强乙醇在胃肠道的首过效应，降低血中乙醇的浓度，同时，药物直接作用于肝代谢酶系统，增强乙醇脱氢酶活性，加速乙醇及其代谢产物的消除速率，减轻其对组织和细胞的损害。解酒功效十分明显，睡眠时间缩短。醒酒恢复时间为62.3分钟，比目前大多数醒酒时间80-100分钟缩短20-40分钟。
2、本发明的配方中，绞股蓝除了含有绞股蓝皂甙外，还含有黄酮类物质、多糖、磷脂、氨基酸和维生素等常量和微量无机元素等活性成份；枳椇子种子含黑麦草碱，β-咔啉，枳椇甙C、D、G、G’和H，其中枳椇甙D和G相应的甙元为酸枣甙元；果实含多量葡萄糖，硝酸钾和苹果酸钾等；甘草含有类似肾上腺皮质激素样作用，对组胺引起的胃酸分泌过多有抑制作用；并有抗酸和缓解胃肠平滑肌痉挛作用；甘草还有抗炎，抗过敏作用，能保护发炎的咽喉和气管粘膜；甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用；甘草常用来治疗随更年期而来的症状，因为甘草里含有甘草素，是一种类似激素的化合物，它有助于平衡女性体内的激素含量。甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用；葛根主要含碳水化合物，植物蛋白多种维生素和矿物质，此外还含有黄酮类物质：大豆素，大豆甙，还有大豆素-4，7-二葡萄糖甙，葛根素，葛根素-7-木糖甙，葛根醇，葛根藤及异黄酮甙等；葛花含1-辛烯-3-醉(1-octen-3-ol)，丁香油酚，芳樟醇，苯甲酸甲酯，丙酸甲酯，异戊酸甲酯，正己酸甲酯大豆素，葛花甙，鹰嘴豆芽素)A，芒柄花甙，降紫香甙等。山楂含有蛋白质，脂肪，膳食纤维，碳水化合物，胡萝卜素，维生素；硫胺素，核黄素，尼g酸；维生素C，维生素E等。由于内含上述多种营养成分，形成了清热祛火、解毒、降血脂、降血糖和减肥等养生功效。本发明的饮品在解酒的同时，具有养生功效。
3、本发明筛选出的饮品配方，通过矫味剂原料的选择及合理配比，所生产的饮料爽口、风味好、口感好，可以作为风味饮料直接饮用。
4、本发明的饮品的制备方法工艺简单，生产成本低。
具体实施方式
以下结合具体实施例对本发明作进一步详细说明。
实施例1
(1)称量含水量在13％以下的绞股蓝5g、甘草3g、枳椇子18g、葛根20g、葛花30g、山楂5g混合，放入提取釜中。向提取釜中注入10倍的纯净水，在70℃条件下浸提2小时，滤渣中再加入8倍量的纯净水，70℃下浸提1.5小时，过滤后合并得到粗滤液。
(2)粗滤液先用纱布过滤，然后用抽滤装置进行硅藻土上过滤，得红褐色滤液。
(3)红褐色滤液用旋转浓缩仪于70℃抽真空浓缩至相当于含可溶性固形物0.5g-0.95g/g，作为母液。
(4)将上述母液移入配料釜中，将白砂糖80g、柠檬酸3g、山梨酸钾0.2g、果味香精1.5g缓慢加入配料釜中，搅拌至溶解；向配料釜中补纯净水，定容至1000毫升，得到饮品粗样。
(5)将配料釜中的饮品粗样经过过滤、均质、灌装、灭菌、包装、检验得到成品。
效果实验：
取试验小白鼠120只，随机分为2组，每组60只，禁食12h后，各组先灌胃，给予白酒(50％)15g/kg体重，当小白鼠醉倒时，立即灌胃给予实施例1的产品，灌胃量为20g/kg体重，作为实验组，记录各组小白鼠从翻正反射消失到恢复的时间。未给予灌胃解酒药的小鼠作为对照组。结果如下表1所示。
表1：解酒饮料对醉酒小白鼠睡眠时间的影响
从对试验结果的极差分析可以看到，本发明的实施例1的产品使试验小白鼠醉酒恢复时间显著缩短。
实施例1所得产品经品尝口味独特，液体醇绵爽口，酸甜适度，生津止渴，口感回味绵长，果香浓郁，并伴有淡淡草本的芳香。
以上所述仅是本发明的优选实施方式，应当指出的是，对于本技术领域的普通技术人员来说，在不脱离本发明原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。
Claims (4)
1.一种解酒养生植物饮品，其特征在于，按照重量份数的原料组成为：绞股蓝1-10，甘草1-7，枳椇子10-25，葛根15-45，葛花10-35，山楂1-10。
2.根据权利要求1所述的解酒养生植物饮品，其特征在于，还包括辅料，所述辅料为矫味剂，所述矫味剂由白砂糖、柠檬酸、山梨酸钾和果味香精组成，按照重量份数白砂糖为6-15，柠檬酸为0.1-0.5，山梨酸钾为0.04，果味香精为0.05-0.2。
3.一种权利要求2所述的解酒养生植物饮品的制备方法，其特征在于，包括下述步骤：
(1)制取含有绞股蓝、甘草、枳椇子、葛根、葛花和山楂提取液的混合液，之后，70℃以下浓缩使得可溶性固形物含量在20％-99.9％作为母液；制取所述母液的原料按照重量份数绞股蓝1-10，甘草1-7，枳椇子10-25，葛根15-45，葛花10-35，山楂1-10；
(2)取所述母液与白砂糖柠檬酸、山梨酸钾和果味香精混合溶解后定容，经过滤、均质、灭菌、灌浆、包装得到解酒养生植物饮品；按照重量份数比母液为0.5-30，白砂糖为6-15，柠檬酸0.1-0.5，山梨酸钾为0.04，果味香精为0.05-0.2。
4.根据权利要求3所述的解酒养生植物饮品的制备方法，其特征在于，所述母液的制备方法如下：
(1)按照重量份数为1-10：1-7：10-25：15-45：10-35：1-10的比例称量含水量在13％以下的绞股蓝、甘草、枳椇子、葛根、葛花、山楂混合，放入提取釜中；
(2)向提取釜中注入10倍的纯净水，在70℃条件下浸提2小时，滤渣中再加入8倍量的纯净水，70℃下浸提1.5小时，过滤后合并得到粗滤液；
(3)粗滤液先用纱布过滤，然后用抽滤装置进行硅藻土上过滤，得红褐色滤液；
(4)红褐色滤液用旋转浓缩仪于70℃抽真空浓缩至相当于含可溶性固形物0.20g-0.99g/g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410292530.8A CN104041900A (zh) | 2014-06-25 | 2014-06-25 | 一种解酒养生植物饮品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410292530.8A CN104041900A (zh) | 2014-06-25 | 2014-06-25 | 一种解酒养生植物饮品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104041900A true CN104041900A (zh) | 2014-09-17 |
Family
ID=51495767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410292530.8A Pending CN104041900A (zh) | 2014-06-25 | 2014-06-25 | 一种解酒养生植物饮品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104041900A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104256625A (zh) * | 2014-10-23 | 2015-01-07 | 甘林林 | 一种解酒酵素及其生产工艺 |
| CN104855624A (zh) * | 2015-05-25 | 2015-08-26 | 苏州市巴马饮品有限公司 | 解酒护肝养生茶及其制备方法 |
| CN106616150A (zh) * | 2016-12-08 | 2017-05-10 | 浙江百寿堂药业有限公司 | 一种中药解酒饮品及其制备方法 |
| CN109717437A (zh) * | 2019-01-27 | 2019-05-07 | 山西智圆行方健康管理咨询有限公司 | 一种解酒复合蜂蜜膏及其制备方法 |
| CN109757573A (zh) * | 2019-03-14 | 2019-05-17 | 天水师范学院 | 一种乌梅枳椇子红茶菌复合饮料及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931270A (zh) * | 2006-09-15 | 2007-03-21 | 福州大学 | 中药醒酒护肝药剂及其制备方法 |
| CN102100803A (zh) * | 2009-12-22 | 2011-06-22 | 沈献礼 | 一种具有解酒功能的保健品组合物及其制备方法 |
| CN103082362A (zh) * | 2013-01-24 | 2013-05-08 | 黄冰 | 中药解酒饮料 |
-
2014
- 2014-06-25 CN CN201410292530.8A patent/CN104041900A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931270A (zh) * | 2006-09-15 | 2007-03-21 | 福州大学 | 中药醒酒护肝药剂及其制备方法 |
| CN102100803A (zh) * | 2009-12-22 | 2011-06-22 | 沈献礼 | 一种具有解酒功能的保健品组合物及其制备方法 |
| CN103082362A (zh) * | 2013-01-24 | 2013-05-08 | 黄冰 | 中药解酒饮料 |
Non-Patent Citations (1)
| Title |
|---|
| 黄亚东等: "葛根醒酒保肝饮料的开发研究", 《酿酒科技》, no. 7, 31 July 2008 (2008-07-31) * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104256625A (zh) * | 2014-10-23 | 2015-01-07 | 甘林林 | 一种解酒酵素及其生产工艺 |
| CN104256625B (zh) * | 2014-10-23 | 2016-03-02 | 甘林林 | 一种解酒酵素及其生产工艺 |
| CN104855624A (zh) * | 2015-05-25 | 2015-08-26 | 苏州市巴马饮品有限公司 | 解酒护肝养生茶及其制备方法 |
| CN106616150A (zh) * | 2016-12-08 | 2017-05-10 | 浙江百寿堂药业有限公司 | 一种中药解酒饮品及其制备方法 |
| CN109717437A (zh) * | 2019-01-27 | 2019-05-07 | 山西智圆行方健康管理咨询有限公司 | 一种解酒复合蜂蜜膏及其制备方法 |
| CN109757573A (zh) * | 2019-03-14 | 2019-05-17 | 天水师范学院 | 一种乌梅枳椇子红茶菌复合饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101264177B (zh) | 一种具有提神清咽利喉作用的压片糖果 | |
| CN102552462B (zh) | 一种泡腾制剂及其制备方法和用途 | |
| CN101416671A (zh) | 一种保健清火茶 | |
| CN104223284B (zh) | 一种功能饮料及其生产方法和用途 | |
| CN102511888B (zh) | 一种枇杷叶罗汉果饮料 | |
| CN102078402B (zh) | 治疗高血压、高血脂和高血糖的中药组合物 | |
| CN106509261A (zh) | 一种无糖凉茶植物组合物及利用其制备饮品和颗粒的方法 | |
| CN104982599A (zh) | 一种植物凉茶浓缩液及低糖植物凉茶饮料 | |
| CN103190659A (zh) | 具有降压降脂和降糖作用的植物饮料及其制备方法和应用 | |
| CN104041900A (zh) | 一种解酒养生植物饮品及其制备方法 | |
| CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
| CN103892396A (zh) | 一种具有降糖降脂功能的保健饮料 | |
| CN109730180A (zh) | 一种降血压、降血脂、降血糖组合物及其制备方法和袋泡茶 | |
| CN107822040A (zh) | 一种干姜肉桂保健果冻的制备方法 | |
| CN105901452A (zh) | 一种苦荞麦饮料及其制备方法 | |
| CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
| CN105249091B (zh) | 菊花罗汉果复合饮料及其制备方法 | |
| KR20120131337A (ko) | 인진쑥, 헛개나무, 민들레, 대추, 갈근 및 오가피의 각각의 추출물을 주성분으로 함유하는 기능성 음료 조성물 | |
| CN109619329A (zh) | 一种黄芪组合物及由其制备的黄芪饮料及其制备方法 | |
| CN103725555A (zh) | 一种辅助降血压的野生芭蕉及牛角蕉保健酒及其制备方法 | |
| CN104666643A (zh) | 一种复方雪菊产品及其制备方法和应用 | |
| CN104522244A (zh) | 无糖罗汉果饮料及其生产方法 | |
| CN112970992A (zh) | 一种适合糖尿病人的固体饮料及制作方法 | |
| CN102132918B (zh) | 一种具有养心安神作用的本草饮料及其制备方法 | |
| CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140917 |